| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;42:61.)
© 2003 American Heart Association, Inc.
Scientific Contribution |
From the Division of Geriatrics, Department of Medicine, University of Chicago Pritzker School of Medicine (M.B.R.), Chicago; the Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University (M.L.D., K.L., D.B.G., P.G., J.S.), Chicago, Illinois; and the Department of Medicine, St. Marys Medical Center (G.C.W.), San Francisco, California.
Correspondence to Jeremiah Stamler, MD, Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 N Lake Shore Drive, Suite 1102, Chicago, IL 60611. E-mail hwe216{at}northwestern.edu
| Abstract |
|---|
|
|
|---|
1.97), with older age (
BORDER="0">1.63/5 years), higher serum cholesterol (
1.30/40.0 mg/dL), cigarettes/d (
2.43/20 cigarettes), past smoking (
1.41), height (
1.17/7 cm), evidence of adverse blood pressure (hazard ratio 1.10/20 mm Hg higher systolic pressure, 1.12 to 1.14/12 mm Hg higher diastolic pressure, 1.87 with history of treated hypertension). It is concluded that major cardiovascular risk factorsserum cholesterol, smoking, and blood pressurein middle age relate significantly to risk of abdominal aortic aneurysm in persons surviving into older age.
Key Words: abdominal aortic aneurysm risk factors prospective studies blood pressure cholesterol smoking
| Introduction |
|---|
|
|
|---|
There are relatively few prospective population studies on relationships of CVD risk factors to AAA, and these have been limited by paucity of risk factor data, short duration of follow-up, small number of cases leading to inclusion of all types of aortic aneurysms regardless of site.1419 This report is from a long-term large population-based study on relationships of major modifiable CVD risk factors, measured in middle-aged employed persons, to CVD incidence and mortality in later life. It assesses prospectively relationships of risk factors to clinically identified nonfatal plus fatal AAA.
| Methods |
|---|
|
|
|---|
This analysis is based on 10 661 men and 8817 women, ages 40 to 64 at baseline, who could have reached at least age 65 in the year 2000. After exclusion of participants with incomplete baseline data, 10 574 men and 8700 women remained for analysis. Participants were excluded for missing values as follows: n=87 cholesterol, n=12 blood pressure, n=6 BMI, n=47 education, n=8 smoking, and n=44 diabetes history. As reported, the time interval for blood drawing affected blood glucose values.22 Therefore, in analyses on plasma glucose and AAA, 1000 women and 1031 men were excluded from whom blood had been taken without a recorded time or for whom more than 65 minutes had passed between oral glucose load and blood drawing.
Follow-Up and Case Ascertainment
Follow-up averaged 30 years. For the entire cohort, the National Death Index was searched periodically for vital status. For all decedents through 1992, death certificates were obtained from states and coded for up to 5 causes of death according to the International Classification of Diseases, 8th Revision (ICD-8).23 For all decedents between 1993 and 2000, information was obtained from the National Death IndexPlus (NDI). NDI provided up to 15 causes of death coded according to the 9th (ICD-9) and 10th (ICD-10) revisions of the International Classification of Diseases.2224 Health Care Financing Administration (HCFA) tapes for Medicare Part A (inpatient) and Part B (outpatient) were obtained for eligible participants for the years 19842000. The tapes contain a record of each Medicare reimbursable medical encounter, including date of service and between 5 and 9 billing codes, based on the International Classification of Diseases, 9th Revision (ICD-9).24 AAA was defined as the first chronological occurrence of any mention of ICD-8 code 441.2, ICD-9 codes 441.3 or 441.4, or ICD-10 codes 171.3 or 171.4 on a death certificate, NDI record, or a Medicare billing record.25,26 Death certificates, NDI, and Medicare encounter records were searched for other CVD, including coronary, peripheral arterial, and cerebrovascular diseases, and for diagnoses of diabetes and chronic obstructive pulmonary disease (COPD). COPD was included because of its association with smoking and its putative association with a generalized defect in collagen-elastin synthesis.27
Statistical Analyses
Crude and age-adjusted rates of AAA were computed per 10 000 person-years of follow-up for each gender separately. Persons with AAA were compared with all other participants for baseline characteristics including age, education, race, serum total cholesterol, current or past smoking, cigarettes smoked per day by current smokers, systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure, The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI) BP stratification,28 history of treated hypertension, major and minor ECG abnormalities, height, weight, body mass index (BMI, in kg/m2), history of diabetes, and 1-hour post-load plasma glucose for nondiabetics. To assess relationships of baseline variables to occurrence of AAA, both continuous and categoric analyses were done. For example, in categoric analyses serum cholesterol was stratified <200, 200 to 239,
240 mg/dL. In continuous analyses, age- and multivariate-adjusted relative risks were first computed for each gender separately using Cox multivariate proportional hazards models.29 The Schoenfeld residuals method was used to assess whether continuous data met the assumption of proportional hazards.30 In final Cox multivariate models, the impact of major risk factors considered togetherwith each adjusted for all otherswas assessed for men and women combined, with control for gender. Several multivariate models were computed, to assess separately the independent relationship of each blood pressure variable to AAA occurrence; also to consider separately the smoking variables, expressed either as current smoker versus never smoker and ex-smoker versus never smoker, or as cigarettes/d for current smokers, without and with ex-smoker versus never smoker in the model. Deliberately, 2 highly correlated variables (eg, systolic and diastolic pressure) were not included in any of the multivariate models given the well-known distortions of coefficients their inclusion can produce. The several multivariate models also served to evaluate robustness of risk factor-AAA relationships. Significance levels were calculated for 2-tailed tests.
| Results |
|---|
|
|
|---|
120/
80 and no antihypertensive drug use); the majority had hypertensive levels. About 18% of men and women had an ECG abnormality.
|
Frequency of Aortic Aneurysm by Type, Data Source, and Gender
During an average follow-up of 30 years, aortic aneurysms were reported for 420 of the 10 574 men and 171 of the 8700 women (Table 2). AAA was the most common aneurysm found, accounting for a majority of cases309 men and 109 women. Most individuals with AAA265 men and 95 womenwere identified from Medicare records only. AAA was the underlying cause of death for only 29 men and 13 women; multiple-cause coding of death certificates was the sole means of case identification for only 25 men and 8 women.
|
Frequency of Coexisting Morbidity
For men and women with AAA, comorbid diseases were commonly identified during follow-up, in a significantly higher proportion than for those without AAA (Table 3). This was consistently the finding for the other cardiovascular diseases, eg, 66% of men and 71% of women with AAA had CHD diagnoses, compared with 40% of men and 30% of women without AAA. Also, chronic obstructive pulmonary disease was reported more commonly in men and women with than without AAA.
|
Relationship of Single CVD Risk Factors Considered Separately to AAA
For 3 continuous major risk factors considered separately (DBP, serum cholesterol, cigarette smoking), findings with the Schoenfeld residuals method were consistent with the proportional hazards assumption of Cox analyses; exceptions were SBP and pulse pressure.
Age was strongly associated with occurrence of AAA: for persons older by 5 years at baseline, hazard ratio was 1.50 for men and 1.62 for women (Table 4). In categoric analyses, rate per 10 000 person-years was nearly 5-fold higher for men ages 60 to 64 than for men ages 40 to 44 at baseline, and over 7-fold greater for older women compared with younger women (tabular data not shown). Age-adjusted relative risk for men compared with women was 3.05 (P<0.001).
|
A history of antihypertensive drug treatment in middle age was significantly related to risk of AAA in older age for men, women, and both genders combinedhazard ratios (HRs) 1.56, 1.91, and 1.69 (Table 4). For DBP, SBP, and across the JNC-VI BP strata, there was for men and for the 2 genders combined a significant gradient of risk of AAA. For pulse pressure, findings were qualitatively similar but quantitatively weaker (t value 1.82 for men, 1.64 for all). Although there was for women no significant relationship of these 4 BP variables to AAA risk, tests for gender/BP interaction were nonsignificant.
For men and women, current smoking at baseline was strongly related to occurrence of AAA, with HRs significantly larger for women than men (3.57 and 2.26 for 20 cigarettes/d versus none) (Table 4). In categoric analyses, HRs were large for current smokers of 1 to 20 cigarettes/d (3.92 for men and 3.91 for women) and for those smoking >20/d (5.74 and 5.39) compared with never smokers (tabular data not shown). For men and the 2 genders combined, former smokers were also at significantly greater risk of AAA (HRs 2.49 and 2.09); test for gender/variable interaction was nonsignificant.
Serum cholesterol at baseline was positively related to risk of AAA in older age for both men and women, HR 1.39 (P<0.001) and 1.22 (P<0.02) for 40 mg/dL higher level (about 1 SD higher) (Table 4). In categoric analyses, for men and women with serum cholesterol
240 mg/dL, compared with those <200 mg/dL, HRs were 2.56 and 1.46 (tabular data not shown).
Risk of AAA was greater with taller stature and greater weight for men and for both genders combined, with no significant gender/variable interaction (Table 4). However, overweight, as measured by body mass index (BMI), was not significantly related to AAA risk.
For persons without a diagnosis of diabetes at baseline, 1-hour post-load plasma glucose was significantly related to AAA for men and borderline significantly related for the 2 genders combined, with no significant gender/variable interaction (Table 4). For women with a history of diabetes, there was a significant association with AAAHR 2.02 (Table 4). However, the association was nonsignificantly inverse for men and for the 2 genders combined, and there was significant evidence for gender/diabetes interaction.
Major ECG abnormalities related significantly to AAA for men and for the 2 genders combined, with no significant evidence of gender/variable interaction (Table 4).
African-American women were at greater AAA risk than other women (HR 2.09), but African-American men were at lesser AAA risk than other men, and the test for gender/race interaction was significant (Table 4).
Relationship of Risk Factors to AAA, Multivariate Analyses
Because most univariate analyses on relationships of major risk factors to AAA showed no significant gender/variable interactions (Table 4), data on men and women were combined in multivariate Cox analyses, with inclusion of gender as an independent variable (Table 5). Findings were consistent across the 5 final Cox models: each blood pressure variable, serum cholesterol, smoking, age, height, and male gender were independently and significantly related to AAA. HRs for serum cholesterol about 1 SD higher (40 mg/dL) were in the range 1.30 to 1.34 (P<0.001); for SBP about 1 SD higher (20 mm Hg), 1.10 (P<0.05); for DBP 1 SD higher (12 mm Hg), 1.12 to 1.14 (P<0.05). A history of drug treatment for hypertension was associated with 87% greater AAA risk. For current smokers overall, use of 20 cigarettes per day was associated with a risk increase of 2.4 to 2.7 times; in categoric models, for current smokers compared with never smokers HR was 5.18; for ex-smokers compared with never smokers HR was 1.41 to 2.01. Risk of AAA was from 2.0 to 2.1 times greater for men than women; 1.64 to 1.67 times greater with age older by 5 years; and 1.17 to 1.19 times greater with height greater by 7 cm (2.8 inches).
|
| Discussion |
|---|
|
|
|---|
Our findings are generally consistent with those reported from other prospective studies. For example, of 7682 men in the Honolulu Heart Program cohort, 138 developed AAA during 20-year follow up (among 174 aortic aneurysm cases of all types). Hypertension, high serum cholesterol, taller stature, and cigarette smoking were associated with greater risk of any aneurysm, but not glycemia or overweight.19 In the Honolulu sample, as in ours, there were few deaths attributed to aneurysm; most, 132 of 174 total cases, were identified from surgical reports.
In the Whitehall cohort, 18 403 men were followed for 18 years. In a nested case-control study of 99 men with fatal aneurysm, including 44 with AAA, mortality was significantly associated with cigarette smoking and diastolic BP, but not with glucose, height, BMI, or cholesterol. Other cardiovascular diseases, including angina and claudication at baseline, were not related to risk of fatal aneurysm.18
Comparatively short follow-up data are available from 3 other studies.1,1517 The American Cancer Society study of 800 000 volunteers identified 519 cases (431 men and 88 women) and reported that hypertension and smoking were more frequently found among decedents from any aortic aneurysm at 6-year follow-up.17 In the Edinburgh Artery Study of peripheral vascular disease, 1592 men and women were screened at ages 55 to 74 by ultrasound; 34 cases of AAA were so identified and 6 more were clinically known. Based on a case-control analysis, with major CVD risk factors assessed 5 years earlier, only cigarette smoking was significantly associated with AAA. Persons with AAA had more clinical and subclinical markers of systemic vascular diseases, including peripheral arterial disease, reduced ankle-brachial index (ABI), and angina than did controls.16 In the Cardiovascular Health Study (CHS), ultrasound screening identified 471 people with AAA among 4741 men and women ages 65 to 90 years who had been screened for baseline risk factors 1 to 4 years earlier. Significant associations were found of AAA with age, male gender, smoking, height, weight, treatment for hypertension, low-density lipoprotein cholesterol, and inversely with high-density lipoprotein cholesterol. Clinical CHD (angina, myocardial infarction) and subclinical CVD (decreased ABI, carotid stenosis, and carotid intimal medial thickening) were more common among AAA cases. Neither glycemia nor blood pressure was significantly associated with AAA.15 During 5-year follow-up, CHS participants with AAA were at higher risk for new CVD events, CVD death, and total mortality than persons with baseline CVD diagnoses other than AAA.1 This suggested to the authors that small AAA, rarely fatal in themselves, were markers for severity of underlying cardiovascular disease.1
Data from large cross-sectional studies are consistent with the prospective data, supporting associations of AAA with male gender, age, cigarette smoking, serum cholesterol, and coexisting cardiovascular diseases.3,11,31 A study of over 75 000 veterans ages 50 to 79 years identified 1031 AAA by ultrasound and reported associations with stature, serum cholesterol, and hypertension. A family history of aneurysm, reported by 5% of these veterans, was associated with a nearly 2-fold greater odds ratio. Diabetes and African-American race were inversely associated with prevalent AAA.3 Other cross-sectional studies also found inverse or no associations of AAA with diabetes and glycemia4,9,32 or with African-American race.3,4 Thus, neither prospective nor cross-sectional studies strongly support an association of diabetes and AAA, in contrast to studies showing diabetes to be a risk factor for other CVD, including coronary and peripheral arterial disease and stroke. This may represent type I error and/or the impact of competing CVD mortality among diabetics. Also, the deleterious effect of diabetes on medium and small arteries may be clinically unimportant for AAA given the large caliber of the aorta.
As to major, minor, and total ECG abnormalities at baseline, generally regarded as indicative of subclinical CVD and present in 18% of CHA participants at baseline, only major ECG abnormalities in men and in the 2 genders combined related significantly to AAA in univariate analyses, but not in multivariate analyses. On the other hand, the 30-year follow-up data show an association of AAA with CHD, stroke, and PVD, as well as COPD. Other studies, including the CHS, have reported a higher likelihood of other CVD among aneurysm patients.1,6,8,31 Studies of children and young adults found associations of aortic (as well as coronary) plaque with lipid and glucose abnormalities, hypertension, and smoking.3336 It is not known whether such aortic lesions observed in youth are precursors of adult aneurysms.
A limitation of the present study is that Medicare records and search of death certificates were used to identify clinical AAA cases. An aneurysm so detected could have been symptomatic, ie, the reason for the medical encounter, or a finding during medical evaluation of other conditions, eg, a CT scan for abdominal pain. Period prevalence of AAA for the CHA cohort of 0.9% based on medical records seems low when compared with rates of up to 5% reported in community sample surveys5,9,10,11,37,38 and over 10% for CHS participants.15 Differences in prevalence across these studies are probably due at least in part to variation in measurement methods and definition of aortic dilation. Thus, one limitation of our study is ascertainment bias, ie, missing of cases. Also, the association of AAA with other comorbidity may be exaggerated, in that sick older people are likely to undergo more diagnostic procedures than well older people and are therefore more likely to have any clinically silent disease detected. Another source of ascertainment bias was baseline age, because older people had longer follow-up in the Medicare database. The Cox method corrects for this bias at least in part by using person-years of observation as the basis for calculating rates.
Aneurysm mortality was low in the CHA cohort, and most cases were identified from Medicare records. Studies relying only on mortality will substantially underestimate occurrence of AAA.19 Our Medicare cases probably represent a mixture of clinically significant and small aneurysms. It is difficult, given the coding procedure, to distinguish them. We have no data on nonfatal aneurysms before age 65 unless the diagnosis was carried forward into Medicare records of survivors. However, the cases we analyzed likely reflect the spectrum of clinically detected disease in the Medicare age group.
Medicare data are a reasonably unbiased source of cases because about 96% of eligible men and women ages 65 and older participate in Medicare.39 Only the records for 19842000 were available to us; lifetime occurrence of AAA and of other CVD are bound to be higher with longer follow-up.
| Conclusions |
|---|
|
|
|---|
Perspectives
Extensive data are now available demonstrating that, for both women and men, favorable levels of all major risk factors in young adulthood and middle ageserum total cholesterol <200 mg/dL, SBP/DBP
120/
80 mm Hg, no current smoking, and no history of diabetes or heart attacklead to low rates (endemic, not epidemic) of CHD, stroke, and all CVD in older age, as well as sizably increased longevity.40 It is a reasonable inference from the findings of the present study that such people at low CHD-CVD risk are also at low risk for clinical abdominal aortic aneurysm. At present, a small minority of young adult and middle-aged men and women are at such low risk. Appropriately then, current strategic priorities for CHD-CVD prevention emphasize efforts by medical care and public health to increase the proportions of low-risk individuals throughout the population. The data here suggest that success in these efforts will also markedly reduce abdominal aortic aneurysm as a major clinical problem for older people. This is yet another important reason to underscore the importance of preventing and controlling all the major risk factors.
| Acknowledgments |
|---|
Received July 23, 2002; first decision August 27, 2002; accepted May 16, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P.E. Norman and J.T. Powell Abdominal Aortic Aneurysm: The Prognosis in Women Is Worse Than in Men Circulation, June 5, 2007; 115(22): 2865 - 2869. [Full Text] [PDF] |
||||
![]() |
M. Al-Omran, S. Verma, T. F. Lindsay, R. D. Weisel, and Y. Sternbach Clinical Decision Making for Endovascular Repair of Abdominal Aortic Aneurysm Circulation, December 7, 2004; 110(23): e517 - e523. [Full Text] [PDF] |
||||
![]() |
T. A. Henriques, J. Huang, S. S. D'Souza, A. Daugherty, and L. A. Cassis Orchidectomy, But Not Ovariectomy, Regulates Angiotensin II-Induced Vascular Diseases in Apolipoprotein E-Deficient Mice Endocrinology, August 1, 2004; 145(8): 3866 - 3872. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |